亚太药业(002370.SZ)：拟5000万元设立全资子公司

Core Viewpoint - Asia-Pacific Pharmaceutical (002370.SZ) plans to establish a wholly-owned subsidiary, Zhejiang Yatai Lizhong Investment Holding Co., Ltd., with a capital of 50 million yuan to enhance its industrial development layout [1] Group 1 - The company aims to improve its strategic development and operational planning through this investment [1] - The subsidiary's name is provisional and will be finalized upon approval from the relevant registration authority [1]